Ribocure Pharmaceuticals Ab
Clinical trials sponsored by Ribocure Pharmaceuticals Ab, explained in plain language.
-
New hope for hepatitis d: experimental drug RBD1016 enters Mid-Stage trial
Disease control OngoingThis study tests whether the drug RBD1016 can safely lower the amount of hepatitis D virus in adults with chronic infection. Fourteen participants will receive either RBD1016 or a placebo over several visits. The main goal is to see if the drug reduces viral levels and to check f…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug RBD4059 tested for heart disease safety
Disease control OngoingThis study tests a new drug called RBD4059 in 30 adults with stable coronary artery disease. The main goal is to check if the drug is safe and to see how it affects the body compared to a placebo. Participants will receive either the drug or a placebo and visit the clinic up to 1…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated May 18, 2026 12:07 UTC